We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
SIMS College of Pharmacy, Affiliated to Acharya Nagarjuna University, Guntur, Andhra Pradesh, India.
Madhunasini Vati is a traditional Ayurvedic polyherbal formulation widely used in the management of diabetes mellitus. The present study aims to evaluate the antidiabetic activity of Madhunasini Vati using experimental models. The formulation contains medicinal plants known for their hypoglycemic and insulin-sensitizing properties, particularly Gymnema sylvestre, which plays a key role in glucose regulation. Antidiabetic activity was assessed by monitoring fasting blood glucose levels, oral glucose tolerance, and changes in body weight. Treatment with Madhunasini Vati showed a significant reduction in blood glucose levels when compared to diabetic control groups, indicating effective glycemic control. The formulation also helped in improving glucose tolerance and preventing diabetes-associated weight loss. These effects may be attributed to enhanced insulin secretion, increased peripheral glucose utilization, and inhibition of intestinal glucose absorption. The findings suggest that Madhunasini Vati possesses promising antidiabetic potential and may serve as a safe and effective herbal therapeutic option for the management of diabetes mellitus.
Madhunasini (Gymnema sylvestre) holds a special place in both Ayurvedic and modern medicine for its anti-diabetic properties. Traditionally referred to as the “sugar destroyer,” Madhunasini is valued for its ability to lower blood sugar levels naturally and suppress the taste and absorption of sugar in the body. The plant is rich in gymnemic acids and other phytochemicals that play multiple roles in diabetes management.(13 )These compounds help restore pancreatic function, stimulate insulin secretion, and increase the utilization of glucose by body tissues. Additionally, Madhunasini’s antioxidant activity helps protect the pancreas and other organs from oxidative damage commonly associated with diabetes ,(12)Modern research supports these traditional claims, with both in vitro and clinical studies demonstrating its effectiveness in reducing blood glucose, improving metabolic health, and aiding in the management of complications linked to diabetes. This makes Madhunasini a well-recognized herbal solution for people seeking holistic approaches to diabetes care[26]
Fig no.01 : Botanical picture of Gymnema sylvestre (Madhunasini).
BOTANICAL DESCRIPTION OF MADHUNASHINI :
Gymnema sylvestre is a perennial, woody climber belonging to the family Asclepiadaceae. It is known for its medicinal use, particularly in diabetes management. The plant is slow-growing and requires support for climbing. It produces small, yellow flowers in lateral umbellate cymes, and its leaves are typically opposite, elliptic or ovate in shape, measuring about 2-6 cm in length and 1-4 cm in width. The plant’s stems are light brown and hairy, while the leaves are green, simple, and have a slightly bitter and astringent taste.
TAXONOMY :
The taxonomic classification of Gymnema sylvestre is as follows:
GEOGRAPHICAL DISTRIBUTION :
Madhunasini is found predominantly in tropical and subtropical regions. It is widely distributed across central and southern India, especially in dry forests up to 600 meters altitude, as well as in Sri Lanka, Malaysia, tropical Africa, and the southern part of China. The plant is particularly common in the Western Ghats, central India, and other parts of the Indian subcontinent.
PLANT MORPHOLOGY :
Habit: Perennial, woody climber.
Leaves: Opposite, usually elliptic or ovate, simple, petiolate, with entire margin and acute apex, and pubescent surfaces. Leaves are 2-6 cm long and 1-4 cm wide.
Flowers: Small, yellow, in axillary and lateral umbels in cymes, with long, ovate, obtuse, pubescent calyx-lobes and campanulate corolla.
Fruits: Follicles are terete and lanceolate, up to 3 inches long.
Stem: Hairy and light brown.
Notable Property: The leaves have the unique property of paralyzing the sweet taste for a few hours after contact.
This robust morphological and taxonomic profile is foundational for the identification and further study of this important medicinal plant.
TRADITIONAL AND AYURVEDIC SIGNIFICANCE :
Madhunashini is a slender woody climber native to tropical forests and revered in Ayurveda and Siddha systems. It is classified as “Medohara” (fat-reducing) and “Pramehahara” (anti-diabetic). The herb promotes metabolic health, supports insulin function, and acts as a natural sugar inhibitor by blocking sugar absorption in the intestines due to compounds like gymnemic acids and gurmarin. It also has anti-inflammatory and antioxidant properties and is traditionally used for rheumatism, ulcers, jaundice, and snakebites in folk medicine, showcasing broad therapeutic potential.
USES IN AYURVEDA AND FOLK MEDICINE :
Traditionally, Madhunashini is used for:
NAME DERIVATION (“SUGAR DESTROYER”) :
The name "Madhunashini" translates literally from Sanskrit as "destroyer of sugar," highlighting its primary traditional role in countering diabetes (Madhumeh). It functions uniquely by blocking the sweet taste on the tongue and inhibiting intestinal sugar absorption, which helps reduce blood glucose levels and sugar cravings. This name is also reflected in other Indian languages like Hindi, where it is called "Gurmar," meaning the same ("sugar destroyer")[8]
Thus, Madhunashini's Ayurvedic and traditional value is deeply rooted in its effective role in diabetes control and metabolic balance, conferred through its bioactive components that modulate sugar metabolism and taste perception [9]
PHYTOCHEMICAL CONSTITUENTS :
EXTRACTION AND ISOLATION METHODS :
Gymnemic acids and other saponins are typically extracted using polar solvents such as methanol or ethanol. The plant material is often dried, pulverized, and extracted under reflux conditions[14]
For saponins and flavonoids, adsorption onto non-polar or slightly polar resins is followed by elution with polar solvents such as methanol or ethanol.
This method is used to separate saponins and flavonoids after defatting, by treating with alkaline solution at room temperature, followed by resin-based separation.
Quantification and purity assessment, especially for gymnemic acids, are performed via High Performance Liquid Chromatography (HPLC)[25]
Advanced modern techniques such as ultrasonic-assisted extraction, microwave-assisted extraction, and supercritical fluid extraction are increasingly adopted to improve yields of flavonoids from natural sources[14]
SUMMARY TABLE :
Table no.1 : Major constituents and their types in Gymnema sylvestre
|
Constituent |
Type |
|
Gymnemic acids |
Triterpenoid saponin. |
|
Gurmarin |
Polypeptide |
|
Saponins |
Oleanane/dammarane types |
|
Flavonoids |
Auxilliary constituents |
|
Alkaloids, etc. |
Various secondary metabolites |
Madhunashini’s phytochemicals are central to its medicinal utility, and extraction/isolation processes have evolved to efficiently harness these bioactive substances for research and clinical applications[9,25,18]
MECHANISM OF ANTI -DIABETIC ACTION
PHARMACOLOGICAL STUDIES :
Pharmacological studies on Madhunasini (Gymnema sylvestre), particularly the Ayurvedic formulation Madhunashini Vati, show significant effects across in-vitro, in-vivo animal, and limited clinical studies.
INVITRO STUDIES :
There is research involving in-vitro multiplication and cultivation techniques of the Madhunasini plant using immature seeds as explants in Murashige and Skoog media. This is relevant for propagation and conservation rather than direct pharmacological activity. Specific in-vitro pharmacological assays like antioxidant or enzyme inhibition were not prominently reported in available sources [19]
IN-VIVO ANIMAL STUDIES:
A substantial body of experimental work includes streptozotocin-induced diabetic rat models where Madhunashini Vati showed:
Toxicity studies report no significant adverse effects at doses up to 4000-7500 mg/kg in mice [15]
CLINICAL STUDIES IN HUMANS:
Specific clinical trial data on Madhunasini in humans are sparse. Some Ayurvedic formulations containing Madhunashini have been evaluated for antidiabetic and neuroprotective effects in humans, but detailed clinical trial outcomes are limited or not well-documented in the searched sources. One abstract mentions clinical evaluation of an Ayurvedic preparation involving Madhunasini, but comprehensive published clinical data appear limited [15]
In summary, Madhunasini has shown promising pharmacological effects mainly demonstrated in animal models with antidiabetic, antioxidant, and neuroprotective benefits supported by in-vivo studies.
Clinical data in humans remain minimal or preliminary.If more detailed clinical trial results are desired, further focused search or specialized databases might be needed.
FORMULATIONS AND DOSAGE FORMS:
Madhunasini, also known as Gudmar or Gymnema sylvestre, is used in various formulations and dosage forms in Ayurveda. These include powders (churna), tablets, capsules, decoctions (kashaya), and extracts, which are tailored for different therapeutic needs and user convenience[10]
POWDER (CHURNA):
The powdered form involves finely ground dried plant material, which can be taken directly with water or honey. The typical dose is about 1-3 grams twice daily .
TABLETS/ CAPSULES:
These are modern dosage forms designed for convenience and longer shelf life, often containing standardized extracts. The typical dosage ranges from 250 to 500 mg of extract, taken twice daily after meals.
DECOCTION (KASHAYA):
This involves boiling the powdered leaves or other parts, reducing it to a concentrated form, and sipping before meals, especially in the morning and evening.
EXTRACTS:
Standardized extracts are used in tablet or capsule forms, ensuring consistent dosage and potency .
DOSAGE RECOMMENDATIONS:
USAGE NOTES:
In summary, Madhunasini is available in multiple formulations, with powders and tablets being the most common for everyday use. Dosages generally range from 1–3 grams of powder or 250–500 mg of extract, taken twice daily, tailored to patient needs under Ayurvedic supervision.
THERAPEUTIC USES BEYOND DIABETES:
Madhunasini (Gymnema sylvestre) has several therapeutic uses beyond diabetes, especially notable for its anti-obesity, and antioxidant effects.
ANTI-OBESITY ACTIVITY :
Madhunasini extracts have demonstrated significant anti-obesity effects in both animal and human studies. Research indicates that it can reduce body weight, food intake, and body mass index, partly by blocking sweet receptors on the tongue, which reduces sugar cravings and overall calorie intake. In animal studies, it has prevented weight gain even on high-fat diets, supporting weight maintenance and reduction[6,11,22,20]
HYPOLIPIDEMIC ACTIVITY:
Madhunasini has shown a capability to lower harmful blood lipids such as LDL cholesterol and triglycerides while increasing beneficial HDL cholesterol.,6These effects contribute to reduced risk factors for cardiovascular diseases. Studies on moderately obese individuals and animals have reported significant decreases in LDL and triglycerides along with improved lipid profiles, supporting its role in managing dyslipidemia [22]
ANTI-OXIDANT POTENTIAL:
Madhunasini contains bioactive compounds like tannins and saponins that provide anti-inflammatory and antioxidant properties. These help in reducing oxidative stress and inflammation, which are key contributors to metabolic disorders including diabetes and obesity. Its antioxidant action aids in protecting organs from damage related to high blood sugar and lipid levels [11]
TOXICITY AND SAFETY PROFILE:
ACUTE & CHRONIC TOXICITY DATA:
CONTRAINDICATIONS:
SAFE THERAPEUTIC DOSE RANGE:
SUMMARY TABLE:
Table no.02 : Safety profile of Madhunasini .
|
PARAMETER |
ANIMAL DATA |
HUMAN RECOMMENDATIONS |
|
Acute Toxicity (LD50) |
7,500 mg/kg (oral, mice) |
- |
|
Chronic Toxicity |
1,000 mg/kg, 30 days (rats) - safe |
- |
|
Safe Dose (Adult) |
125–500 mg/kg (rat, mouse studies) |
1–2 tablets, twice daily (500mg/tablet) |
|
Contraindications |
- |
Pregnancy, lactation, allergy, children |
|
Adverse Effects |
- |
Hypoglycemia, GI discomfort, allergy |
LIMITATIONS AND RESEARCH GAP:
STANDARDIZATION ISSUES:
LIMITED CLINICAL EVIDENCE :
NEED FOR MOLECULAR RESEARCH:
Table no.03 : Summary table of need for molecular research .
|
ASPECT |
CURRENT CHALLENGES |
RESEARCH NEEDS |
|
Limitations |
Few large clinical trials; safety data gaps |
Large RCTs; long-term safety studies |
|
Standardization |
Variable quality, no universal standards |
Global standards for quality and bioactives |
|
Clinical Evidence |
Restricted human trial evidence;mostly short-term |
Robust clinical trials with larger cohorts |
|
Molecular Research |
Mechanisms not fully understood |
Molecular, genomic, proteomic studies |
Overall, Madhunasini holds promise but requires multidisciplinary research efforts to overcome current standardization, medical assessment, and molecular rationale shortfall and safe therapeutic use[9]
CONCLUSION:
Madhunasini (Gymnema sylvestre) is a traditional medicinal plant with considerable therapeutic potential, especially in managing diabetes and related metabolic disorders. Its unique properties such as reducing the ability to taste sweetness, lowering blood sugar levels, aiding insulin production, and improving lipid profiles make it a beneficial adjunct therapy for diabetes. It also shows potential benefits in weight management and inflammation reduction. Despite its promising effects, Madhunasini’s clinical use is limited by variability in product standardization, insufficient large-scale clinical trials, and a need for comprehensive molecular studies to better understand its mechanisms of action. Safety data are generally positive within recommended doses, but long-term effects and impacts in special populations require further research. In conclusion, Madhunasini is a potent herbal remedy with multi-faceted benefits for metabolic health, particularly diabetes. Continued research efforts in standardization, clinical validation, and molecular pharmacology are essential to fully harness its potential and establish it as a reliable therapeutic agent in modern medicine. When properly administered with clinical oversight ,it offers a safe and effective complement to conventional diabetes treatments .
REFERENCES
Thota Srinivas, Unnagiri Nandini, Thangabalan B, A Review on Anti-Diabetic Activity of Madhunasini Plant (Gymnema Sylvestre), Int. J. of Pharm. Sci., 2026, Vol 4, Issue 1, 2343-2353. https://doi.org/10.5281/zenodo.18340298
10.5281/zenodo.18340298